Aurora Cannabis (ACB) Competitors $5.28 -0.24 (-4.26%) As of 01:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. ETNB, AUPH, GYRE, MLYS, WVE, PAHC, ARDX, COLL, NTLA, and RCUSShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include 89bio (ETNB), Aurinia Pharmaceuticals (AUPH), Gyre Therapeutics (GYRE), Mineralys Therapeutics (MLYS), Wave Life Sciences (WVE), Phibro Animal Health (PAHC), Ardelyx (ARDX), Collegium Pharmaceutical (COLL), Intellia Therapeutics (NTLA), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. 89bio Aurinia Pharmaceuticals Gyre Therapeutics Mineralys Therapeutics Wave Life Sciences Phibro Animal Health Ardelyx Collegium Pharmaceutical Intellia Therapeutics Arcus Biosciences Aurora Cannabis (NASDAQ:ACB) and 89bio (NASDAQ:ETNB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Which has stronger valuation & earnings, ACB or ETNB? Aurora Cannabis has higher revenue and earnings than 89bio. 89bio is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$320.81M0.97-$48.62M$0.05110.4089bioN/AN/A-$142.19M-$3.38-2.90 Do insiders & institutionals believe in ACB or ETNB? 47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 2.6% of 89bio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor ACB or ETNB? In the previous week, 89bio had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 11 mentions for 89bio and 3 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.19 beat 89bio's score of 0.90 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 89bio 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ACB or ETNB? 89bio has a consensus target price of $26.43, suggesting a potential upside of 169.40%. Given 89bio's higher probable upside, analysts plainly believe 89bio is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.6789bio 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more volatility & risk, ACB or ETNB? Aurora Cannabis has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. Comparatively, 89bio has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Does the MarketBeat Community believe in ACB or ETNB? Aurora Cannabis received 269 more outperform votes than 89bio when rated by MarketBeat users. However, 61.83% of users gave 89bio an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% 89bioOutperform Votes11561.83% Underperform Votes7138.17% Is ACB or ETNB more profitable? Aurora Cannabis has a net margin of 0.42% compared to 89bio's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat 89bio's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis0.42% 0.59% 0.42% 89bio N/A -59.58%-52.21% SummaryAurora Cannabis beats 89bio on 12 of the 17 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$310.30M$1.23B$5.38B$8.47BDividend YieldN/AN/A5.28%4.17%P/E Ratio110.4211.8326.9919.79Price / Sales0.979.85412.17137.59Price / Cash26.3510.4038.2534.64Price / Book0.671.516.844.53Net Income-$48.62M-$56.07M$3.22B$247.85M7 Day Performance0.36%5.27%2.47%2.44%1 Month Performance18.97%4.05%9.71%10.64%1 Year Performance-10.24%-32.21%20.95%10.45% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.5613 of 5 stars$5.29-4.3%N/A-10.5%$297.09M$320.81M105.721,340Positive NewsETNB89bio2.3975 of 5 stars$7.70-1.0%$26.43+243.2%+22.3%$1.12BN/A-2.6540Positive NewsAUPHAurinia Pharmaceuticals3.3847 of 5 stars$8.07-1.5%$11.50+42.5%+54.8%$1.09B$247.30M-53.80300Positive NewsGYREGyre Therapeutics0.1222 of 5 stars$11.11-2.1%N/A-4.9%$1.04B$100.64M555.5040News CoverageGap UpMLYSMineralys Therapeutics2.9913 of 5 stars$15.32-0.2%$38.00+148.0%+27.2%$998.48MN/A-4.2128WVEWave Life Sciences4.3604 of 5 stars$6.46+2.1%$21.17+227.7%+4.0%$995.71M$104.94M-5.82240Positive NewsPAHCPhibro Animal Health3.6673 of 5 stars$24.13+0.5%$20.00-17.1%+35.9%$978.09M$1.19B50.271,860Positive NewsARDXArdelyx4.6321 of 5 stars$4.06+4.6%$10.39+155.9%-39.0%$971.38M$361.71M-25.3890COLLCollegium Pharmaceutical4.0407 of 5 stars$29.83-1.3%$43.80+46.8%-12.1%$958.50M$664.28M12.86210Positive NewsNTLAIntellia Therapeutics4.6125 of 5 stars$9.06+6.6%$36.90+307.3%-65.6%$938.46M$45.57M-1.67600Trending NewsAnalyst ForecastHigh Trading VolumeRCUSArcus Biosciences2.5614 of 5 stars$8.70+1.6%$25.67+195.0%-37.3%$921.20M$141M-2.76500Short Interest ↑ Related Companies and Tools Related Companies 89bio Competitors Aurinia Pharmaceuticals Competitors Gyre Therapeutics Competitors Mineralys Therapeutics Competitors Wave Life Sciences Competitors Phibro Animal Health Competitors Ardelyx Competitors Collegium Pharmaceutical Competitors Intellia Therapeutics Competitors Arcus Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts